ID: ALA2396931

Max Phase: Preclinical

Molecular Formula: C11H13N3O2

Molecular Weight: 219.24

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(O)c(C2CC(=O)NC(N)=N2)c1

Standard InChI:  InChI=1S/C11H13N3O2/c1-6-2-3-9(15)7(4-6)8-5-10(16)14-11(12)13-8/h2-4,8,15H,5H2,1H3,(H3,12,13,14,16)

Standard InChI Key:  RHGIZRPOIZIHSA-UHFFFAOYSA-N

Associated Targets(Human)

Growth factor receptor-bound protein 2 663 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 219.24Molecular Weight (Monoisotopic): 219.1008AlogP: 0.58#Rotatable Bonds: 1
Polar Surface Area: 87.71Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.47CX Basic pKa: 6.71CX LogP: 0.85CX LogD: 0.77
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.65Np Likeness Score: 0.29

References

1. Simister PC, Luccarelli J, Thompson S, Appella DH, Feller SM, Hamilton AD..  (2013)  Novel inhibitors of a Grb2 SH3C domain interaction identified by a virtual screen.,  21  (14): [PMID:23182216] [10.1016/j.bmc.2012.10.023]

Source